未登录

R

Rajesh Ramanathan

virginia commonwealth university

H指数:27

被引数:2,837

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma

SMAD4丢失与胰腺癌患者对新辅助化疗加羟氯喹的反应有关

CTS-CLINICAL AND TRANSLATIONAL SCIENCE

IF2.8

2021-05-1818

OAAI

Phase II Trial of Adjuvant Dendritic Cell Vaccine in Combination with Celecoxib, Interferon-α, and Rintatolimod in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2021-01-0523

OAAI

Generation of fully functional hepatocyte-like organoids from human induced pluripotent stem cells mixed with Endothelial Cells

SCIENTIFIC REPORTS

IF3.9

2019-06-20120

OAAI

Angiopoietin pathway gene expression associated with poor breast cancer survival

BREAST CANCER RESEARCH AND TREATMENT

IF3

2017-01-0647

OA

Paradoxical Association of Postoperative Plasma Sphingosine-1-Phosphate with Breast Cancer Aggressiveness and Chemotherapy

MEDIATORS OF INFLAMMATION

IF4.2

2017-01-014

OAAI

[18F]2-fluoro-2-deoxyglucose (FDG) positron emission tomography (PET) response and survival analysis in a phase 1/2 trial of nab-paclitaxel (nab-P) plus gemcitabine (gem) for metastatic pancreatic cancer (MPC)

EUROPEAN JOURNAL OF CANCER

IF7.1

2016-12-010

PREAI

Correlation of venous thromboembolism prophylaxis and electronic medical record alerts with incidence among surgical patients

IF2.7

2016-11-019

PREAI

Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential (vol 2016, 8606878, 2016)

MEDIATORS OF INFLAMMATION

IF4.2

2016-10-2416

OAAI

First-in-human phase 1, dose-escalation and -expansion study of ABBV-399, an antibody-drug conjugate (ADC) targeting c-Met, in patients (pts) with advanced solid tumors

ANNALS OF ONCOLOGY

IF65.4

2016-10-012

OAAI

Scalable Differentiation of Human iPSCs in a Multicellular Spheroid-based 3D Culture into Hepatocyte-like Cells through Direct Wnt/β-catenin Pathway Inhibition

SCIENTIFIC REPORTS

IF3.9

2016-09-1259

OAAI

The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases

JOURNAL OF LIPID RESEARCH

IF4.1

2016-09-0188

OAAI

Positron emission tomography (PET) as a predictive measure in patients with metastatic pancreatic cancer and normal CA19-9 levels at baseline

ANNALS OF ONCOLOGY

IF65.4

2016-08-010

OAAI

Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential

MEDIATORS OF INFLAMMATION

IF4.2

2016-01-01124

OAAI

Transplantation of human stem cell-derived hepatocytes in an animal model of acute liver failure

IF2.7

2015-08-0115

PREAI

nab-Paclitaxel (nab-P) plus gemcitabine (Gem) for patients with advanced pancreatic cancer who have cholestatic hyperbilirubinemia (CH) secondary to bile duct obstruction: a phase I safety and pharmacokinetics study

ANNALS OF ONCOLOGY

IF65.4

2015-06-010

OAAI

Local Allograft Irradiation as an Adjunct for Treating Severe Resistant Rejection After Liver Transplantation in Adults

LIVER TRANSPLANTATION

IF3.9

2014-12-223

PREAI

Multimodality Therapy and Liver Transplantation for Hepatocellular Carcinoma: A 14-Year Prospective Analysis of Outcomes

TRANSPLANTATION

IF5

2014-07-1522

OAAI

Direct Cell-Cell Interaction With Primary Liver Cells Is Required for Complete Maturation of Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells.

TRANSPLANTATION

IF5

2014-07-010

OAAI

Racial Disparities in Surgical Hepatocellular Carcinoma Care Do Not Seem to Affect Patient Outcomes.

TRANSPLANTATION

IF5

2014-07-010

PREAI

Kidney Re-Transplantation Versus Continued Dialysis in Patients With Primary Graft Failure.

TRANSPLANTATION

IF5

2014-07-010

PREAI